Trial Profile
A Phase II/III Double-Blind, Randomized, Placebo-Controlled Trial of the Safety and Efficacy of Isolagen Therapy in the Treatment of Moderate to Sever Facial Acne Scarring
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 15 Jan 2021
Price :
$35
*
At a glance
- Drugs Azficel-T (Primary)
- Indications Scars
- Focus Therapeutic Use
- Sponsors Castle Creek Pharmaceuticals; Fibrocell Science
- 27 May 2014 New trial record